AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance - Concepedia

Concepedia

Publication | Open Access

AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance

DOI Full Paper Access

1.2K

Citations

27

References

2009

Year

Thomas O’Hare, William C. Shakespeare, Xiaotian Zhu, Christopher A. Eide, Victor M. Rivera, Frank Wang, Lauren T. Adrian, Tianjun Zhou, Wei-Sheng Huang, Qihong Xu,

Hematological MalignancyTumor BiologyChronic Myeloid LeukemiaOncologyPan-bcr-abl InhibitorT315i MutantMedicineAdult T-cell Leukemia-lymphomaPharmacologyCell BiologyCancer ResearchMyeloid Neoplasia

References

	Year	Citations

Page 1

Page 1